SavedAdd your journal

Journals / The anatolian journal of family medicine (Online) / 2019 / Cilt: 2 - Sayı: 3

The Role of Bilirubin in Rheumatoid Arthritis as a Biomarker

TUBA TÜLAY KOCA
Ejder BERK
Pages
98–102
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

As a practical biomarkerwith anti-oxidative properties, the DBb can be used in clinical follow-up in RA.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objectives: Serum bilirubin (Bb) has an anti-inflammatory biologic effect through its antioxidant component.The present study aims to reveal the importance of serum Bb in Rheumatoid arthritis (RA) as a biomarker.Methods: This study was designed as a case-control study.
📊
Key Findings & Data:Seventy-five RA patients with age (p=0.31) andgender matched 75 controls were included in this study.
💡
Conclusion & Impact:As a practical biomarkerwith anti-oxidative properties, the DBb can be used in clinical follow-up in RA.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Özet

Objectives: Serum bilirubin (Bb) has an anti-inflammatory biologic effect through its antioxidant component.The present study aims to reveal the importance of serum Bb in Rheumatoid arthritis (RA) as a biomarker.Methods: This study was designed as a case-control study. Seventy-five RA patients with age (p=0.31) andgender matched 75 controls were included in this study. Clinical characteristics and laboratory parameterswere analyzed retrospectively. Serum direct Bb (DBb), indirect Bb (InBb), total Bb (TBb), erythrocyte sedimentation rate (ESR) and C-reactive protein (CRP) data were recorded. Disease activity in RA was assessed using theDisease Activity Score 28 (DAS28).Results: In this study, acute phase reactants, CRP (p<0.01) and ESR (p<0.01) were significantly higher in ourstudy group; DBb was found significantly lower (p<0.01) than the control group. ESR was negatively correlatedwith DBb, InBb and TBb respectively (p=0.029, r=-0.252; p=0.003; r=- 0.362; p=0.009, r=-0.302). TBb was notcorrelated with DAS 28 (p=0.08; r=-0.203).Conclusion: We found that DBb was significantly lower in RA patients than the patients in the control group.All Bb parameters were negatively correlated with acute phase reactants and DAS28. As a practical biomarkerwith anti-oxidative properties, the DBb can be used in clinical follow-up in RA.

🔖

Cite This Article

KOCA, T. T., BERK, E. (2019). The Role of Bilirubin in Rheumatoid Arthritis as a Biomarker. The anatolian journal of family medicine (Online), Cilt: 2 - Sayı: 3, 98–102. https://ajindex.com/articles/365077

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (17)

  1. Majithia V, Geraci SA. Rheumatoid arthritis: diagnosis and management. Am J Med 2007;120(11):936–9
  2. Glant TT, Mikecz K, Rauch TA. Epigenetics in the pathogenesis of rheumatoid arthritis. BMC Med 2014;12:35
  3. Firestein GS. The disease formerly known as rheumatoid arthritis. Arthritis Res Ther 2014;16(3):114
  4. García-González A, Gaxiola-Robles R, Zenteno-Savín T. Oxidative stress in patients with rheumatoid arthritis. Rev Invest Clin 2015;67(1):46–53
  5. Veselinovic M, Barudzic N, Vuletic M, Zivkovic V, Tomic-Lucic A, Djuric D, et al. Oxidative stress in rheumatoid arthritis patients: relationship to diseases activity. Mol Cell Biochem 2014;391(1-2):225-32
  6. Lequerré T, Rottenberg P, Derambure C, Cosette P, Vittecoq O. Predictors of Treatment Response in Rheumatoid Arthritis. Joint Bone Spine 2018;86(2):151–8
  7. Jangi S, Otterbein L, Robson S. The molecular basis for the immunomodulatory activities of unconjugated bilirubin. Int J Biochem Cell Biol 2013;45(12):2843–51
  8. Khan NM, Poduval TB. Immunomodulatory and immunotoxic effects of bilirubin: molecular mechanisms. J Leukoc Biol 2011;90(5):997–1015
  9. Nishimura K, Sugiyama D, Kogata Y, Tsuji G, Nakawaza T, Kawano S, et al. Meta-analysis: diagnostic accuracy of anticyclic citrullinated peptide antibody and rheumatoid factor for rheumatoid arthritis. Ann Int Med 2007;146(11):797–808
  10. Chimenti MS, Triggianese P, Conigliaro P, Candi E, Melino G, Perricone R. The interplay between inflammation and metabolism in rheumatoid arthritis. See comment in PubMed Commons below. Cell Death Dis 2015;6:e1887
  11. Sanmartí R, Gómez-Puerta JA. Biomarkers in rheumatoid arthritis. Rheumatol Clin 2011;6S3:S25–8
  12. Smallwood MJ, Nissim A, Knight AR, Whiteman M, Haigh R, Winyard PG. Oxidative stress in autoimmune rheumatic diseases. Free Radic Biol Med 2018;125:3–14
  13. Mateen S, Moin S, Zafar A, Khan AQ. Redox signaling in rheumatoid arthritis and the preventive role of polyphenols. Clin Chim Acta 2016;463:4–10
  14. Vítek L. Relationship of bilirubin to diseases caused by increased oxidative stress. Vnitr Lek 2013;59(7):618–21
  15. Cacciapaglia F, Anelli MG, Rizzo D, Morelli E, Scioscia C, Mazzotta D, et al. Influence of TNF-α inhibition on oxidative stress of rheumatoid arthritis patients. Reumatismo 2015;67(3):97– 102
  16. Mateen S, Moin S, Khan AQ, Zafar A, Fatima N. Increased Reactive Oxygen Species Formation and Oxidative Stress in Rheumatoid Arthritis. PLoS One 2016;11(4):e0152925
  17. Lee Y, Kim H, K